Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
SPRY compared with MLYS: revenue, margins and what each company keeps, and the suppliers and customers both name
SPRY
ARS Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
MLYS
Mineralys Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
SPRY
ARS Pharmaceuticals, Inc.
vs
MLYS
Mineralys Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
SPRY, solid
MLYS, dashed
SPRY
ARS Pharmaceuticals, Inc.
Change
2.79
▲
+5.09%
· post 2.79
Mkt cap
$280.5M
Revenue
$38M
Q3 FY26
Revenue
$84M
FY25
MLYS
Mineralys Therapeutics, Inc.
Change
15.33
▲
+0.59%
· post 15.33
Closed
Nov 6 '26
Mkt cap
$1.4B
Revenue
—
Revenue
—
vs
Compare
Closed
Nov 6 '26
SPRY
ARS Pharmaceuticals, Inc.
vs
MLYS
Mineralys Therapeutics, Inc.
2.79
▲
+5.09%
post 2.79
Price
15.33
▲
+0.59%
post 15.33
$280.5M
Mkt cap
$1.4B
Q3 FY26
$38M
Revenue
—
FY25
$84M
Revenue
—
Change
Change
SPRY
2.79
▲
+5.09%
vs
MLYS
15.33
▲
+0.59%
Closed
Nov 6 '26